Search results
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks via Yahoo Finance· 4 days agoAbbVie ABBV announced that the FDA has granted approval to its blockbuster drug, Skyrizi to treat...
AbbVie Inc. (NYSE:ABBV) Shares Sold by Cox Capital Mgt LLC
ETF DAILY NEWS· 20 hours agoCox Capital Mgt LLC decreased its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 5.3% during the 1st quarter, HoldingsChannel reports. The institutional investor ...
AbbVie Inc. (NYSE:ABBV) Stock Holdings Boosted by Inscription Capital LLC
ETF DAILY NEWS· 19 hours agoInscription Capital LLC raised its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 20.9% in the first quarter, according to the company in its most recent 13F ...
AbbVie Inc. (NYSE:ABBV) Shares Bought by Pathway Financial Advisors LLC
ETF DAILY NEWS· 19 hours agoPathway Financial Advisors LLC raised its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.7% in the 1st quarter, according to its most recent filing with the SEC. The ...
JD Supra: AbbVie Files Notice of Data Breach Impacting the Health Information of Tens of Thousands...
JD Supra· 15 hours agoOn May 22, 2024, AbbVie, Inc. filed a notice of data breach with the Attorney General of Texas after discovering that confidential information that had been entrusted to the ...
AbbVie (NYSE:ABBV) Stock Rating Reaffirmed by Cantor Fitzgerald
ETF DAILY NEWS· 1 day agoAbbVie (NYSE:ABBV – Get Free Report)‘s stock had its “overweight” rating reissued by Cantor Fitzgerald in a note issued to investors on Thursday, Benzinga reports. Cantor ...
American National Bank Acquires 1,816 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 18 hours agoAmerican National Bank grew its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 3.1% during the first quarter, according to its most recent filing with the ...
AbbVie (ABBV) Exceeds Market Returns: Some Facts to Consider
Zacks via Yahoo Finance· 4 days agoThe latest trading session saw AbbVie (ABBV) ending at $171.36, denoting a +0.99% adjustment from...
AbbVie names Roxanne Austin as new lead independent director By Investing.com
Investing.com· 3 days agoAustin will be taking over from Glenn F. Tilton, who will continue his tenure on the board as an...
AbbVie (NYSE:ABBV) Given New $190.00 Price Target at Piper Sandler
ETF DAILY NEWS· 5 days agoAbbVie (NYSE:ABBV – Get Free Report) had its price objective boosted by research analysts at Piper Sandler from $185.00 to $190.00 in a research note issued on Tuesday, Benzinga ...